2005
DOI: 10.1016/s0016-5107(05)00287-7
|View full text |Cite
|
Sign up to set email alerts
|

EUS-guided FNA of pancreatic metastases: a multicenter experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
134
2
3

Year Published

2008
2008
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 145 publications
(142 citation statements)
references
References 24 publications
3
134
2
3
Order By: Relevance
“…In such cases, endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration may aid in the accurate differentiation. 10 MTPs may occur after a prolonged time after the diagnosis of the primary tumor, [3][4][5]9 with reports of time interval longer than 30 years. 11 In our study, the longest interval was 14.2 years.…”
Section: Discussionmentioning
confidence: 99%
“…In such cases, endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration may aid in the accurate differentiation. 10 MTPs may occur after a prolonged time after the diagnosis of the primary tumor, [3][4][5]9 with reports of time interval longer than 30 years. 11 In our study, the longest interval was 14.2 years.…”
Section: Discussionmentioning
confidence: 99%
“…Although most solid pancreatic masses are pancreatic ductal adenocarcinomas (PDAC), several differential diagnoses should be suspected, including pancreatic neuroendocrine tumors (PNET), focal chronic pancreatitis and, rarely, metastatic lesions in the pancreas (MP) [1,2,3]. Reports on the characteristics that can be used to differentiate MP from PDAC based on endoscopic ultrasound (EUS) findings alone are scarce [1,3].…”
Section: Introductionmentioning
confidence: 99%
“…Neither the size of lesion nor the number of needle passes was predictive of complications (15). The complication rate after EUS-FNAB from pancreatic masses including hypervascular tumors, such as metastatic lesions from RCC and HCC appears to be acceptably low (18). In the present case, we utilized EUS-FNAB for the preoperative definite diagnosis and assessed the lesion extent.…”
Section: A B C D Creas Is Very Rare Accounting For 3 To 106% Of Allmentioning
confidence: 78%